BEIJING, Dec. 18, 2025 /PRNewswire/ -- Syneron Bio, an macrocyclic peptide drug discovery company driven by intelligent high-throughput platform, has successfully completed its Series A and A+ ...

The consumer-goods giant teams up with the small cap to treat consumers' skin. While Cramer focused on the company's new dental lasers, another area that had been simmering in the oven sent the stock ...

YOKNEAM, Israel & WAYLAND, Mass.--(BUSINESS WIRE)--Syneron Medical Ltd. (NASDAQ:ELOS) and Candela Corporation (NASDAQ:CLZR) announced today that they have entered into a definitive agreement to ...

IRVINE, Calif. and LONDON, April 3, 2017 /PRNewswire/ — Syneron Medical Ltd. (NASDAQ: ELOS), a leading global non-surgical aesthetic device company, and Apax Partners, a leading global private equity ...

NEW YORK (AP) -- Syneron Medical Ltd. on Wednesday posted a smaller loss in the first quarter despite a decline in sales, helped by lower costs. The Israeli company makes devices designed to treat ...

There's no foolproof way to know the future for Syneron Medical (Nasdaq: ELOS) or any other company. However, certain clues may help you see potential stumbles before they happen -- and before your ...

Acquisition of Danish Ellipse adds globally renowned IPL and laser technologies to Syneron Candela's portfolio, further strengthening their position in multi-application, multi-technology devices ...

Syneron has been a serial disappointer, and a long position is a contrarian play with some risk. But there's legitimate progress in newer products, with sales seemingly solid and the SG&A line ...

Louis P. Scafuri, Chief Executive Officer of Syneron, commented, "During the second quarter we achieved strong financial results, including our third consecutive quarter with record revenue. Strong ...

Apax Partners LLC has agreed to buy Syneron Medical Ltd. for $397 million in cash. Syneron Medical—also known as Syneron Candela—is based in Israel and maintains a U.S. headquarters in Irvine under ...

Israel-based Syneron and Palomar settled the case just three weeks before it was due to go before a Massachusetts court. Syneron has agreed to pay Palomar Medical Technologies $31 million in cash and ...